5401 - 5410 of 8093 Results
Title
Year
-
RESTRICTEDTitle: Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?Journal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 4Start Page: 453End Page: 462Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/ejn.14314Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.14314Citation Count: 15
-
RESTRICTEDTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Citation Count: 0
-
RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 53
-
OPENTitle: miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signalingJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1295-1Best OA location URL: https://www.nature.com/articles/s41419-018-1295-1.pdfCitation Count: 64
- Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs2019RESTRICTEDTitle: Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 148Issue #:Start Page: 220End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.01.015Citation Count: 13
-
RESTRICTEDTitle: